The effects of L-659,066, a peripheral α2-adrenoceptor antagonist, on dexmedetomidine-induced sedation and bradycardia in dogs

Veterinary Anaesthesia and Analgesia

Volumn 35, Issue 5, 2008, Pages 409-413

  Honkavaara, Juhana M ^a   Raekallio, Marja R ^a   Kuusela, Erja K ^a   Hyvärinen, Esko A ^b   Vainio, Outi M ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Atipamezole; Dexmedetomidine; Dog; Heart rate; L 659,066; Sedation

Indexed keywords

ANIMALIA; CANIS FAMILIARIS;

EID: 49549114901     PISSN: 14672987     EISSN: 14672995     Source Type: Journal    
DOI: 10.1111/j.1467-2995.2008.00403.x     Document Type: Article

References (14)

1. Alibhai HIK, Clarke KW, Lee YH et al. (1996) Cardiopulmonary effects of combinations of medetomidine hydrochloride and atropine sulphate in dogs. Vet Rec 138, 11 13.
2. Bloor BC, Frankland M, Alper G et al. (1992) Hemodynamic and sedative effects of dexmedetomidine in dogs. J Vet Pharmacol Ther 263, 690 697.
3. Clineschmidt BV, Pettibone DJ, Lotti VR et al. (1988) A peripherally acting alpha-2 adrenoceptor antagonist: L-659,066. J Pharmacol Exp Ther 245, 32 40.
4. EMEA (2001) Committee for veterinary medicinal products, Guidelines for the conduct of bioequivalence studies for veterinary medicinal products, 2001. Available at: http://www.emea.europa.eu/pdfs/ewp/001600en.pdf (11/07/2001)
5. Honkavaara JH, Raekallio RM, Vainio OM (2006) The peripheral alpha2-adrenergic antagonist L659,066 prevents the early dexmedetomidine-induced cardiopulmonary effects in sheep. Proceedings of the 9th World Congress of Veterinary Anaesthesiology. Santos, Brazil. pp. 158 (abstract).
6. Hyvärinen E, Ruuskanen I, Hyttinen J et al. (2006) Mental stress analysis instrumentation and tools based on heart rate variability. Proceedings of the 18th International EURASIP Conference, Biosignal 2006. Brno, Czech Republic. pp. 196 198 (abstract).
7. Ko JC, Fox SM, Mandsager RE (2000) Sedative and cardiorespiratory effects of medetomidine, medetomidine-butorphanol, and medetomidine-ketamine in dogs. J Am Vet Med Assoc 216, 1578 1583.
8. Ko JC, Fox SM, Mandsager RE (2001) Effects of preemptive atropine administration on incidence of medetomidine-induced bradycardia in dogs. J Am Vet Med Assoc 218, 52 58.
9. Kuusela E, Raekallio MR, Anttila M et al. (2000) Clinical effects and pharmacokinetics of medetomidine and its enantiomers. J Vet Pharmacol Ther 23, 15 20.
10. Murrell JC, Hellebrekers LJ (2005) Medetomidine and dexmedetomidine. A review of cardiovascular effects and antinociceptive properties in the dog. Vet Anaesth Analg 32, 117 127.
11. 2-adrenoceptor antagonist attenuates the early, but preserves the late cardiovascular effects of intravenous dexmedetomidine in conscious dogs. J Cardiothorac Vasc Anesth 12, 429 434.
12. Pypendop BH, Verstegen JP (1998) Hemodynamic effects of medetomidine in the dog: a dose titration study. Vet Surg 27, 612 622.
13. Short CE (1991) Effects of anticholinergic treatment on the cardiac and respiratory systems in dogs sedated with medetomidine. Vet Rec 129, 310 313.
14. Vainio O (1990) Reversal of medetomidine-induced cardiovascular and respiratory changes with atipamezole in dogs. Vet Rec 127, 447 450.